Deal · acquisition
Roche Holding AG / Carmot Therapeutics Inc.
Announced Dec 4, 2023 · closed
Deal terms
- Parties
- Roche Holding AG · Carmot Therapeutics Inc.
- Deal type
- acquisition
- Territory
- Global
- Closing date
- Jan 31, 2024
- Upfront
- $2.7 billion
- Milestones
- $400 million
- Royalties
- None disclosed
- Equity terms
- None disclosed
- Headline value
- $3.1 billion (contingent on milestones)
Assets
View all →Sources
- company-releaseprimary record
Roche to acquire Carmot Therapeutics including CT-388 and CT-996
Roche Holding AG · Roche Media Release · Dec 4, 2023